Abstract:Fetal cutaneous wounds that occur in early gestation heal without scar formation. Although much work has been done to characterize the role of transforming growth factor-beta (TGF-beta) isoforms and their receptors in the wound healing process, their roles in scarless wound repair observed in early gestation and their functions in human fetal skin development, and structural and functional maintenance are still not well understood. In this study, we explore the expression and distribution characteristics of three TGF-beta isoforms and their receptors, TGF-betaRI (TBRI) and TGF-betaRII (TBRII), in fetal and postnatal skins to understand the relevance of these five proteins to skin development and elucidate the mechanism(s) underlying the phenotypic transition from scarless to scar-forming healing observed during fetal gestation. Fetal skin biopsies of human embryo were obtained from spontaneous abortions at different gestational ages from 13 to 32 weeks and postnatal skin specimens were collected from patients undergoing plastic surgery. Gene expression and positive immunohistochemical signals of TGF-beta(1), TGF-beta(2), TGF-beta(3), TBRI, and TBRII could all be detected in fetal and postnatal skins. In early gestation, gene expression of TGF-beta(1), TBRI, and TBRII was weaker and protein contents were less compared with postnatal skins (p < 0.05). In contrast, more TGF-beta(2) mRNA transcript was found in early gestation than in late gestation and in postnatal skins, whereas protein content of this growth factor increased during gestation. Lastly, mRNA transcript and protein contents of TGF-beta(3) were apparently higher in early gestation compared to postnatal skin (p < 0.05). In postnatal skin, granules containing the three TGF-beta isoforms were mainly distributed in the cytoplasm and extracellular matrix of epidermal cells, interfollicular keratinocytes, and some fibroblasts. TBRI and TBRII were chiefly located in the cellular membrane of epidermal keratinocytes and some fibroblasts. The endogenous three TGF-beta isoforms and their receptors may be involved in the development of embryonic skin and in the maintenance of cutaneous structure and function, and also in postnatal wound healing. The differential levels of TGF-beta isoforms may provide either a predominantly antiscarring or profibrotic signal upon wounding depending on the gestational period. Lower expression of their receptors in early gestational skins may be a reason for the reduced ability to perceive ligands, ultimately leading to scar-free healing.

Theoretical and Practical Aspects of Using Fetal Fibroblasts for Skin Regeneration

Improved Dermal Regeneration Using a Combination of Dermal Substitutes and Dermal Fibroblast Optimization: A Hypothesis.

Co-transfection of Hepatocyte Growth Factor and Truncated TGF-β Type II Receptor Inhibit Scar Formation

Advances in scarless foetal wound healing and prospects for scar reduction in adults

Embryonic skin development and repair

Gene Therapy of Scarring: a Lesson Learned from Fetal Scarless Wound Healing.

Fibroblasts: Heterogeneous Cells With Potential in Regenerative Therapy for Scarless Wound Healing

Fetal Skin Wound Healing: Key Extracellular Matrix Components and Regulators in Scarless Healing

The Progress and Challenges for Dermal Regeneration in Tissue Engineering.

Ontogeny of Expression of Transforming Growth Factor‐β and Its Receptors and Their Possible Relationship with Scarless Healing in Human Fetal Skin

Basic Fibroblast Growth Factor in Scarless Wound Healing

TGF-β: A Fibrotic Factor in Wound Scarring and a Potential Target for Anti- Scarring Gene Therapy

Novel Prospects for Scarless Wound Healing: the Roles of Myofibroblasts and Adipocytes.

[Scarless Fetal Wound Healing and Its Mechanism].

Scarring Skin: Mechanisms and Therapies

[Tissue Engineered Skin and Regenerative Wound Repair].

Cell therapy for full-thickness wounds: are fetal dermal cells a potential source?

Diversity of fibroblasts--a review on implications for skin tissue engineering

Mechanisms and Therapies

Modulating embryonic signaling pathways paves the way for regeneration in wound healing

Human Amniotic Fluid Stem Cell-Derived Exosomes as a Novel Cell-Free Therapy for Cutaneous Regeneration